Logo image of CDM1.DE

COEUR MINING INC (CDM1.DE) Stock Fundamental Analysis

FRA:CDM1 - Deutsche Boerse Ag - US1921085049 - Common Stock - Currency: EUR

7.91  +0.03 (+0.43%)

Fundamental Rating

5

Overall CDM1 gets a fundamental rating of 5 out of 10. We evaluated CDM1 against 36 industry peers in the Metals & Mining industry. CDM1 has only an average score on both its financial health and profitability. CDM1 is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CDM1 was profitable.
CDM1 had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CDM1 reported negative net income in multiple years.
CDM1 had a positive operating cash flow in each of the past 5 years.
CDM1.DE Yearly Net Income VS EBIT VS OCF VS FCFCDM1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

CDM1's Return On Assets of 2.98% is in line compared to the rest of the industry. CDM1 outperforms 55.56% of its industry peers.
The Return On Equity of CDM1 (4.42%) is comparable to the rest of the industry.
CDM1 has a Return On Invested Capital (3.15%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 2.98%
ROE 4.42%
ROIC 3.15%
ROA(3y)-2.22%
ROA(5y)-1.33%
ROE(3y)-4.55%
ROE(5y)-2.78%
ROIC(3y)N/A
ROIC(5y)N/A
CDM1.DE Yearly ROA, ROE, ROICCDM1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

CDM1's Profit Margin of 10.11% is fine compared to the rest of the industry. CDM1 outperforms 77.78% of its industry peers.
CDM1 has a better Operating Margin (21.38%) than 75.00% of its industry peers.
CDM1's Operating Margin has improved in the last couple of years.
CDM1's Gross Margin of 44.65% is fine compared to the rest of the industry. CDM1 outperforms 72.22% of its industry peers.
In the last couple of years the Gross Margin of CDM1 has grown nicely.
Industry RankSector Rank
OM 21.38%
PM (TTM) 10.11%
GM 44.65%
OM growth 3Y30%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.95%
GM growth 5Y13.16%
CDM1.DE Yearly Profit, Operating, Gross MarginsCDM1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

4

2. Health

2.1 Basic Checks

CDM1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CDM1 has been increased compared to 1 year ago.
The number of shares outstanding for CDM1 has been increased compared to 5 years ago.
The debt/assets ratio for CDM1 has been reduced compared to a year ago.
CDM1.DE Yearly Shares OutstandingCDM1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CDM1.DE Yearly Total Debt VS Total AssetsCDM1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.18 indicates that CDM1 is not a great score, but indicates only limited risk for bankruptcy at the moment.
CDM1 has a Altman-Z score of 2.18. This is comparable to the rest of the industry: CDM1 outperforms 58.33% of its industry peers.
The Debt to FCF ratio of CDM1 is 7.48, which is on the high side as it means it would take CDM1, 7.48 years of fcf income to pay off all of its debts.
CDM1's Debt to FCF ratio of 7.48 is in line compared to the rest of the industry. CDM1 outperforms 52.78% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that CDM1 is not too dependend on debt financing.
CDM1 has a better Debt to Equity ratio (0.17) than 63.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 7.48
Altman-Z 2.18
ROIC/WACC0.36
WACC8.63%
CDM1.DE Yearly LT Debt VS Equity VS FCFCDM1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

CDM1 has a Current Ratio of 1.93. This is a normal value and indicates that CDM1 is financially healthy and should not expect problems in meeting its short term obligations.
CDM1's Current ratio of 1.93 is fine compared to the rest of the industry. CDM1 outperforms 61.11% of its industry peers.
CDM1 has a Quick Ratio of 1.09. This is a normal value and indicates that CDM1 is financially healthy and should not expect problems in meeting its short term obligations.
CDM1 has a Quick ratio (1.09) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.09
CDM1.DE Yearly Current Assets VS Current LiabilitesCDM1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

7

3. Growth

3.1 Past

CDM1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 283.33%, which is quite impressive.
Looking at the last year, CDM1 shows a very strong growth in Revenue. The Revenue has grown by 41.80%.
The Revenue has been growing by 8.18% on average over the past years. This is quite good.
EPS 1Y (TTM)283.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%320%
Revenue 1Y (TTM)41.8%
Revenue growth 3Y8.17%
Revenue growth 5Y8.18%
Sales Q2Q%69%

3.2 Future

Based on estimates for the next years, CDM1 will show a very strong growth in Earnings Per Share. The EPS will grow by 34.10% on average per year.
CDM1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.01% yearly.
EPS Next Y281.23%
EPS Next 2Y104.22%
EPS Next 3Y79.29%
EPS Next 5Y34.1%
Revenue Next Year57.43%
Revenue Next 2Y25.25%
Revenue Next 3Y22.28%
Revenue Next 5Y16.01%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CDM1.DE Yearly Revenue VS EstimatesCDM1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
CDM1.DE Yearly EPS VS EstimatesCDM1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 -1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.28, CDM1 can be considered very expensive at the moment.
CDM1's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.34. CDM1 is around the same levels.
CDM1 is valuated correctly with a Price/Forward Earnings ratio of 12.81.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CDM1 is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.19. CDM1 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 27.28
Fwd PE 12.81
CDM1.DE Price Earnings VS Forward Price EarningsCDM1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CDM1 indicates a slightly more expensive valuation: CDM1 is more expensive than 69.44% of the companies listed in the same industry.
CDM1's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. CDM1 is more expensive than 61.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 87.16
EV/EBITDA 15.67
CDM1.DE Per share dataCDM1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CDM1's earnings are expected to grow with 79.29% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2Y104.22%
EPS Next 3Y79.29%

0

5. Dividend

5.1 Amount

No dividends for CDM1!.
Industry RankSector Rank
Dividend Yield N/A

COEUR MINING INC

FRA:CDM1 (6/19/2025, 7:00:00 PM)

7.91

+0.03 (+0.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners76.39%
Inst Owner ChangeN/A
Ins Owners1.07%
Ins Owner ChangeN/A
Market Cap5.06B
Analysts80
Price Target8.82 (11.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1208.25%
Min EPS beat(2)-22.21%
Max EPS beat(2)2438.72%
EPS beat(4)3
Avg EPS beat(4)632.66%
Min EPS beat(4)-22.21%
Max EPS beat(4)2438.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.87%
Min Revenue beat(2)-6.45%
Max Revenue beat(2)12.19%
Revenue beat(4)2
Avg Revenue beat(4)0.95%
Min Revenue beat(4)-9.25%
Max Revenue beat(4)12.19%
Revenue beat(8)3
Avg Revenue beat(8)-5.57%
Revenue beat(12)5
Avg Revenue beat(12)-3.74%
Revenue beat(16)5
Avg Revenue beat(16)-3.92%
PT rev (1m)5.95%
PT rev (3m)3.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)44.35%
EPS NY rev (1m)0%
EPS NY rev (3m)4.17%
Revenue NQ rev (1m)-1.43%
Revenue NQ rev (3m)9.51%
Revenue NY rev (1m)1.72%
Revenue NY rev (3m)8.33%
Valuation
Industry RankSector Rank
PE 27.28
Fwd PE 12.81
P/S 4.84
P/FCF 87.16
P/OCF 22.53
P/B 2.11
P/tB 2.66
EV/EBITDA 15.67
EPS(TTM)0.29
EY3.67%
EPS(NY)0.62
Fwd EY7.81%
FCF(TTM)0.09
FCFY1.15%
OCF(TTM)0.35
OCFY4.44%
SpS1.64
BVpS3.74
TBVpS2.97
PEG (NY)0.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.98%
ROE 4.42%
ROCE 6.75%
ROIC 3.15%
ROICexc 3.21%
ROICexgc 3.79%
OM 21.38%
PM (TTM) 10.11%
GM 44.65%
FCFM 5.55%
ROA(3y)-2.22%
ROA(5y)-1.33%
ROE(3y)-4.55%
ROE(5y)-2.78%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y27.91%
ROICexcg growth 5YN/A
ROICexc growth 3Y27.91%
ROICexc growth 5YN/A
OM growth 3Y30%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.95%
GM growth 5Y13.16%
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 7.48
Debt/EBITDA 1.17
Cap/Depr 135.76%
Cap/Sales 15.91%
Interest Coverage 250
Cash Conversion 64.83%
Profit Quality 54.9%
Current Ratio 1.93
Quick Ratio 1.09
Altman-Z 2.18
F-Score7
WACC8.63%
ROIC/WACC0.36
Cap/Depr(3y)275.87%
Cap/Depr(5y)228.93%
Cap/Sales(3y)35.55%
Cap/Sales(5y)31.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)283.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%320%
EPS Next Y281.23%
EPS Next 2Y104.22%
EPS Next 3Y79.29%
EPS Next 5Y34.1%
Revenue 1Y (TTM)41.8%
Revenue growth 3Y8.17%
Revenue growth 5Y8.18%
Sales Q2Q%69%
Revenue Next Year57.43%
Revenue Next 2Y25.25%
Revenue Next 3Y22.28%
Revenue Next 5Y16.01%
EBIT growth 1Y2523.57%
EBIT growth 3Y40.62%
EBIT growth 5YN/A
EBIT Next Year380.87%
EBIT Next 3Y86.89%
EBIT Next 5Y38.3%
FCF growth 1Y118.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8807.43%
OCF growth 3Y16.39%
OCF growth 5Y13.65%